Zoll Medical landed a contract with the U.S. Defense Dept. worth $400 million to supply vital signs monitors, the Pentagon said yesterday.
The 1-year deal includes 5 1-year extension options, according to a press release. There were 2 other bidders for the contract, which will see Zoll supply its vital signs monitors to the Army and Air Force, the Defense Dept. said.
Japan’s Asahi Kasei (TYO:3407) in 2012 paid $2.3 billion to acquire Chelmsford, Mass.-based Zoll. Former CEO Rick Packer, who led Zoll for 13 years before overseeing the merger, was promoted in March to primary executive officer and charged with building the healthcare business into “a 3rd pillar” of the Asahi Kasei Group.
The conglomerate, which is also in the construction and chemical & fiber businesses, said the healthcare unit will consist of Zoll, Asahi Kasei Pharma, Asahi Kasei Medical and “future global healthcare companies.”
Packer, who’s presided over a doubling in sales at Zoll to more than $1 billion since the April 2012 merger, was also named non-executive chairman. Zoll also promoted president Jonathan Rennert to replace Packer as CEO, and moved international SVP Ernest Whiton into the president role.
Also in March, the company won approval from Japan’s Pharmaceuticals & Medical Devices Agency for its Thermogard XP temperature management system for patients in sudden cardiac arrest.
